Andrew Brief, MD
Foot and Ankle Surgery · Ridgewood, NJNPI 1841206653
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $236,182 of the $253,186 with a category attached, or 93.3%. 22 manufacturers reported payments, led by Medartis Inc. at 38.0% of the total. Reporting peaked in 2022 at $90,019 and has fallen 71.0% since, to $26,130 in 2025. Among foot and ankle surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $1758.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medartis Inc.$96K
- Extremity Medical$77K
- Nextremity Solutions Inc.$67K
- Seapearl East, Inc$3K
- Stryker$3K
- Synthes USA Products LLC$3K
- plus $4K from 16 others
What the payments were for
- Royalty or licence$236,18293%
- Consulting fees$8,4903%
- Travel & lodging$2,4921%
- Food & beverage$5,1292%
- Education$7990%
- Gifts$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medartis Inc. | 15 | $96,291 |
| Extremity Medical | 29 | $76,695 |
| Nextremity Solutions Inc. | 10 | $67,491 |
| Seapearl East, Inc | 17 | $3,206 |
| Stryker(2 entities) | 21 | $3,037 |
| Synthes USA Products LLC | 4 | $2,883 |
| Arthrex | 11 | $1,144 |
| Bioventus LLC | 7 | $924 |
| Johnson & Johnson | 10 | $319 |
| Kerecis Limited | 6 | $311 |
| Arteriocyte Medical Systems, Inc. | 2 | $284 |
| Biocomposites Inc | 1 | $150 |
| Paragon 28, Inc. | 1 | $131 |
| Fusion Orthopedics USA, LLC | 1 | $128 |
| Solventum Corporation | 1 | $40 |
| Pacira Pharmaceuticals Incorporated | 2 | $27 |
| KCI USA, Inc. | 1 | $26 |
| Integra Lifesciences Corporation | 1 | $26 |
| Axogen | 1 | $25 |
| Smith+Nephew | 1 | $24 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APTUS$96,232
- OMNI$88,392
- NA$2,847
- LCP$2,847
- Exogen$768
- GAMMA$454
- Magellan$284
- CITREFIX$173
- Stimulan$150
- INFINITY ADAPTIS$144
- INBONE$144
- ADAPT$144
- T2$144
- INFINITY$132
- R3FLEX$131
- DISTAL EXTREMITIES IMPLANTS TRAUMA ANKLE FRACTURE$120
- AUGMENT$115
- DISTAL EXTREMITIES INSTRUMENTS FRACTURE MANAGEMENT SMALL FRAGMENT$110
- ASNIS$108
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$107
How this compares
$253,186 in reported general payments places this provider in the 95th percentile of 542 foot and ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 21 | $180 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Ridgewood
- Jacob ReinkrautRidgewood$80K
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Keith CookNewark$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.